← All trials
NCT06044350
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2023
- Primary completion
- May 31, 2025
- Completion date
- May 31, 2026
- First posted
- Sep 21, 2023
- Last posted
- Sep 21, 2023
- Enrollment
- 162
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- BiotheraLead sponsor
- North Sichuan Medical UniversityOverall official - principal investigator
- Anhui Medical UniversityOverall official - principal investigator
- Fujian Medical UniversityOverall official - principal investigator
- Soochow UniversityOverall official - principal investigator
- Hebei UniversityOverall official - principal investigator
- Henan Provincal People's HospitalOverall official - principal investigator
- Fudan UniversityOverall official - principal investigator
- Anhui Medical UniversityOverall official - principal investigator
- Nanchang UniversityOverall official - principal investigator
- Soochow UniversityOverall official - principal investigator
- Shandong UniversityOverall official - principal investigator
- Fudan UniversityOverall official - principal investigator
- Sun Yat-Sen UniversityOverall official - principal investigator
- Dalian Medical UniversityOverall official - principal investigator
- Shanxi Medical UniversityOverall official - principal investigator
- Zhengzhou UniversityOverall official - principal investigator
- Peking UniversityOverall official - principal investigator
- Guangzhou Medical UniversityOverall official - principal investigator
- Tianjin Medical UniversityOverall official - principal investigator
- Zhengzhou UniversityOfficial
- North Sichuan Medical UniversityOfficial
- Guangzhou Medical UniversityOfficial
- Fujian Medical UniversityOfficial
- Hebei UniversityOfficial
- Fudan UniversityOfficial
- Fudan UniversityOfficial
- Soochow UniversityOfficial
- Soochow UniversityOfficial
- Sun Yat-Sen UniversityOfficial
- Shanxi Medical UniversityOfficial
- Nanchang UniversityOfficial
- Shandong UniversityOfficial
- Dalian Medical UniversityOfficial
- Henan Provincal People's HospitalOfficial
- Tianjin Medical UniversityOfficial
- Anhui Medical UniversityOfficial
- Anhui Medical UniversityOfficial
- Peking UniversityOfficial
- Shanghai University of Traditional Chinese MedicineOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.